Rovati GE - Search Results

1

Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I.

Sokolowska M, Rovati GE, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, Sava F, Angelina A, Palomares O, Akdis CA, O'Mahony L, Sanak M, Dahlen SE, Woszczek G. Sokolowska M, et al. Among authors: rovati ge. Allergy. 2021 Jan;76(1):114-130. doi: 10.1111/all.14295. Allergy. 2021. PMID: 32279330 Free article. Review.

2

Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19.

Sokolowska M, Rovati GE, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, Sava F, Angelina A, Palomares O, Akdis CA, O'Mahony L, Jesenak M, Pfaar O, Torres MJ, Sanak M, Dahlén SE, Woszczek G. Sokolowska M, et al. Among authors: rovati ge. Allergy. 2022 Aug;77(8):2337-2354. doi: 10.1111/all.15258. Epub 2022 Feb 25. Allergy. 2022. PMID: 35174512 Free PMC article.

3

International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.

Bäck M, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Bäck M, et al. Among authors: rovati ge. Pharmacol Rev. 2011 Sep;63(3):539-84. doi: 10.1124/pr.110.004184. Pharmacol Rev. 2011. PMID: 21771892 Review.

4

Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk.

Rovati GE, Sala A, Capra V, Dahlén SE, Folco G. Rovati GE, et al. Trends Pharmacol Sci. 2010 Mar;31(3):102-7. doi: 10.1016/j.tips.2009.11.007. Epub 2010 Feb 1. Trends Pharmacol Sci. 2010. PMID: 20117851

5

Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Bäck M, Powell WS, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Bäck M, et al. Among authors: rovati ge. Br J Pharmacol. 2014 Aug;171(15):3551-74. doi: 10.1111/bph.12665. Epub 2014 Jul 12. Br J Pharmacol. 2014. PMID: 24588652 Free PMC article. Review.

6

International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor.

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T. Brink C, et al. Among authors: rovati ge. Pharmacol Rev. 2004 Mar;56(1):149-57. doi: 10.1124/pr.56.1.4. Pharmacol Rev. 2004. PMID: 15001665 Review.

7

Leukotriene modifiers in asthma management.

Capra V, Rovati GE. Capra V, et al. Among authors: rovati ge. IDrugs. 2004 Jul;7(7):659-66. IDrugs. 2004. PMID: 15243868 Review.

8

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.

Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. Chiang N, et al. Among authors: rovati ge. Pharmacol Rev. 2006 Sep;58(3):463-87. doi: 10.1124/pr.58.3.4. Pharmacol Rev. 2006. PMID: 16968948 Review.

9

Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.

Capra V, Bäck M, Barbieri SS, Camera M, Tremoli E, Rovati GE. Capra V, et al. Among authors: rovati ge. Med Res Rev. 2013 Mar;33(2):364-438. doi: 10.1002/med.21251. Epub 2012 Mar 20. Med Res Rev. 2013. PMID: 22434418 Review.

10

Leukotrienes as mediators of asthma.

Nicosia S, Capra V, Rovati GE. Nicosia S, et al. Among authors: rovati ge. Pulm Pharmacol Ther. 2001;14(1):3-19. doi: 10.1006/pupt.2000.0262. Pulm Pharmacol Ther. 2001. PMID: 11162414 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters